News by Tag: Roche
Cri-report - Risk - Reward of Developing a Herceptin Biosimilar - A Thorough Assessment
October 16, 2012
Herceptin exclusivity is expiring in major geographies and many Biosimilar players (both experienced and new entrant) are looking to have a share of this potential $6billion pie. Herceptin sales are critical to Roche as it comprise about 15% of its c
October 16, 2012
Herceptin exclusivity is expiring in major geographies and many Biosimilar players (both experienced and new entrant) are looking to have a share of this potential $6billion pie. Herceptin sales are critical to Roche as it comprise about 15% of its c
RNCOS Publishes a New Company Report - Roche - Company
May 23, 2011
RNCOS has recently released "Roche - Company Analysis" The study provides an overview of the core businesses of the company, a brief company history, its mergers and acquisitions, etc.
May 23, 2011
RNCOS has recently released "Roche - Company Analysis" The study provides an overview of the core businesses of the company, a brief company history, its mergers and acquisitions, etc.
Technological Innovations driving US Blood Glucose Monitoring Market
May 11, 2011
As the companies are striving for more technological innovations in the blood glucose monitoring products, the industry is bound to grow in the coming years, says RNCOS in its latest research study.
May 11, 2011
As the companies are striving for more technological innovations in the blood glucose monitoring products, the industry is bound to grow in the coming years, says RNCOS in its latest research study.